Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - bóluefni - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
kabiven perifer innrennslislyf, fleyti
fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; natrii glycerophosphas; calcium chloride dihydrate - innrennslislyf, fleyti
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
kabiven innrennslislyf, fleyti
fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; natrii glycerophosphas; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; calcium chloride dihydrate - innrennslislyf, fleyti
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
influvactetra (influvac tetra) stungulyf, dreifa í áfylltri sprautu 15/15/15/15 míkróg/skammt
viatris aps - b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð); a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2)- líkur stofn (a/darwin/9/2021, san-010); b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - stungulyf, dreifa í áfylltri sprautu - 15/15/15/15 míkróg/skammt
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
oculac (heilsa) augndropar, lausn í stakskammtaíláti 50 mg/ml
heilsa ehf. - povidone k25 - augndropar, lausn í stakskammtaíláti - 50 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
havrix stungulyf, dreifa 1440 elisa ein./ml
glaxosmithkline pharma a/s - lifrarbólguveira a (deydd) - stungulyf, dreifa - 1440 elisa ein./ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
stamaril stungulyfsstofn og leysir, dreifa
sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
natriumklorid baxter viaflo 9 mg/ml innrennslislyf, lausn 9 mg/ml
baxter medical ab* - sodium chloride - innrennslislyf, lausn - 9 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
smofkabiven extra nitrogen innrennslislyf, fleyti
fresenius kabi ab - alaninum inn; argininum inn; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum dihydricum inn; natrii glycerophosphas; magnesium sulfate heptahydrate; kalii chloridum; natrii acetas; zinc sulphate heptahydrate; glucose monohydrate; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; fish oil rich in omega-3 acids - innrennslislyf, fleyti
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
mannitol baxter viaflo innrennslislyf, lausn 150 mg/ ml
baxter medical ab* - mannitolum - innrennslislyf, lausn - 150 mg/ ml